Chapter 13. Prostaglandins and Leukotrienes

  1. Prof. Dr. Michael Bader
  1. Katharina Lötzer and
  2. Andreas J. R. Habenicht

Published Online: 4 FEB 2009

DOI: 10.1002/9783527626236.ch13

Cardiovascular Hormone Systems: From Molecular Mechanisms to Novel Therapeutics

Cardiovascular Hormone Systems: From Molecular Mechanisms to Novel Therapeutics

How to Cite

Lötzer, K. and Habenicht, A. J. R. (2008) Prostaglandins and Leukotrienes, in Cardiovascular Hormone Systems: From Molecular Mechanisms to Novel Therapeutics (ed M. Bader), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany. doi: 10.1002/9783527626236.ch13

Editor Information

  1. Max Delbrück Center for Molecular Medicine (MDC), Robert-Rössle-Strasse 10, 13092 Berlin, Germany

Author Information

  1. Friedrich Schiller University, Institute for Vascular Medicine, Bachstrasse 18, 07743 Jena, Germany

Publication History

  1. Published Online: 4 FEB 2009
  2. Published Print: 10 SEP 2008

ISBN Information

Print ISBN: 9783527319206

Online ISBN: 9783527626236

SEARCH

Keywords:

  • prostaglandin;
  • leukotriene;
  • arachidonic acid;
  • cyclooxygenase;
  • 5-lipoxygenase;
  • cardiovascular effect

Summary

This chapter contains sections titled:

  • AA Metabolism by the COX and 5-LO Pathways

  • PGs in Cardiovascular Physiology and Pathophysiology

  • LTs in Cardiovascular Physiology and Pathophysiology

  • References